Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome




Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; for the ELIXA Investigators

2015

New England Journal of Medicine

373

23

2247

2257

11

0028-4793

DOIhttps://doi.org/10.1056/NEJMoa1509225




Last updated on 2024-26-11 at 20:45